Abstract |
Previous studies have shown that tumor cells predominantly express Th2 type cytokines and transcription factors. GATA-3, as a Th2-specific transcription factor, plays a central role in positive-regulating Th2 development. So whether the expression of GATA-3 in tumor cells has any effect on tumor development is a question of interest. In the present study, we inhibited the expression of GATA-3 in tumor cells through antisense RNA blockade technique, and observed its effects on tumor in vitro and in vivo. Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice. We suggest that the ratio of T-bet/GATA-3 can be evaluated as a more important marker of the status of Th1/Th2 type. And our results might provide some evidence about the molecular regulatory mechanisms in tumor cell development.
|
Authors | Dongzhu Yao, Xiaojun Zhang, Haiming Wei, Zhigang Tian |
Journal | Cellular & molecular immunology
(Cell Mol Immunol)
Vol. 2
Issue 3
Pg. 189-96
(Jun 2005)
ISSN: 1672-7681 [Print] China |
PMID | 16212886
(Publication Type: Journal Article)
|
Chemical References |
- Cytokines
- GATA3 Transcription Factor
- RNA, Antisense
- Tumor Necrosis Factor-alpha
|
Topics |
- Animals
- Cell Line, Tumor
- Cloning, Molecular
- Cytokines
(metabolism)
- GATA3 Transcription Factor
(biosynthesis, deficiency, genetics, metabolism)
- Gene Expression Regulation
- Gene Expression Regulation, Neoplastic
- Humans
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Neoplasms
(immunology, metabolism, pathology)
- RNA, Antisense
(genetics, metabolism)
- Spleen
(metabolism)
- Th1 Cells
(immunology, metabolism)
- Th2 Cells
(immunology, metabolism)
- Transfection
- Tumor Necrosis Factor-alpha
(metabolism)
|